ATE359774T1 - Taurinderivate verwendbar in der behandlung von netzhauterkrankungen - Google Patents

Taurinderivate verwendbar in der behandlung von netzhauterkrankungen

Info

Publication number
ATE359774T1
ATE359774T1 AT98962016T AT98962016T ATE359774T1 AT E359774 T1 ATE359774 T1 AT E359774T1 AT 98962016 T AT98962016 T AT 98962016T AT 98962016 T AT98962016 T AT 98962016T AT E359774 T1 ATE359774 T1 AT E359774T1
Authority
AT
Austria
Prior art keywords
methods
taurine derivatives
nonatetraen
cyclohexen
imido
Prior art date
Application number
AT98962016T
Other languages
English (en)
Inventor
Andranik M Petrosian
Jasmine E Haroutounian
Armen Vartanian
Original Assignee
Karageozian Hampar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Karageozian Hampar filed Critical Karageozian Hampar
Application granted granted Critical
Publication of ATE359774T1 publication Critical patent/ATE359774T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT98962016T 1997-12-10 1998-12-09 Taurinderivate verwendbar in der behandlung von netzhauterkrankungen ATE359774T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/982,249 US6391924B1 (en) 1997-12-10 1997-12-10 Taurine derivatives useable in the treatment of ophthalmic disorders

Publications (1)

Publication Number Publication Date
ATE359774T1 true ATE359774T1 (de) 2007-05-15

Family

ID=25528983

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98962016T ATE359774T1 (de) 1997-12-10 1998-12-09 Taurinderivate verwendbar in der behandlung von netzhauterkrankungen

Country Status (9)

Country Link
US (1) US6391924B1 (de)
EP (1) EP1037622B1 (de)
JP (1) JP2001525362A (de)
CN (1) CN1191827C (de)
AT (1) ATE359774T1 (de)
CA (1) CA2312842C (de)
DE (1) DE69837622T2 (de)
ES (1) ES2286864T3 (de)
WO (1) WO1999029315A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2161982C1 (ru) * 2000-01-20 2001-01-20 Общество с ограниченной ответственностью "Клиника Института биорегуляции и геронтологии" Тетрапептид, стимулирующий функцию сетчатой оболочки глаза, фармакологическое средство на его основе и способ его применения
DE10035620B4 (de) * 2000-07-21 2005-07-14 *Acri.Tec Gesellschaft für ophthalmologische Produkte mbH Verwendung von Taurin als neuroprotektives Agens in der Ophthalmologie
EP3326623A1 (de) 2003-03-14 2018-05-30 University of Washington Retinoidersätze und opsinagonisten sowie verfahren zur verwendung davon
NZ587006A (en) 2004-06-18 2011-12-22 Univ Washington 11-cis-Retinal derivatives and methods for the use thereof for the treatment of visual disorders
WO2009102418A1 (en) 2008-02-11 2009-08-20 University Of Washington Methods for the treatment and prevention of age-related retinal dysfunction
AU2015200520B2 (en) * 2008-02-11 2017-02-09 University Of Washington Methods for the treatment and prevention of age-related retinal dysfunction
CN102612375B (zh) 2009-09-15 2016-01-27 Qlt股份有限公司 含有在脂质媒介物中的9-顺式-视黄酯的药物制剂
CN107308143A (zh) 2010-04-19 2017-11-03 诺维利昂治疗股份有限公司 用于治疗或改善与内源性类视黄醇缺乏有关的视觉障碍的治疗方案和方法
JP6576636B2 (ja) 2012-03-01 2019-09-18 ノベリオン セラピューティクス インコーポレイテッド 内因性レチノイド欠乏に関連する視覚障害における視覚機能を改善するための治療的計画および方法
CN103720641A (zh) * 2013-11-25 2014-04-16 中国中医科学院中药研究所 牛磺酸眼用在体凝胶制剂及其制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0680964A (ja) * 1991-12-27 1994-03-22 Sogo Yatsukou Kk 活性酸素消去剤

Also Published As

Publication number Publication date
CA2312842C (en) 2010-03-09
JP2001525362A (ja) 2001-12-11
US6391924B1 (en) 2002-05-21
CA2312842A1 (en) 1999-06-17
EP1037622A4 (de) 2002-11-06
DE69837622D1 (de) 2007-05-31
DE69837622T2 (de) 2008-01-03
EP1037622A1 (de) 2000-09-27
WO1999029315A1 (en) 1999-06-17
EP1037622B1 (de) 2007-04-18
CN1191827C (zh) 2005-03-09
ES2286864T3 (es) 2007-12-01
CN1290162A (zh) 2001-04-04

Similar Documents

Publication Publication Date Title
ES2152556T3 (es) Composiciones que contienen derivados del acido hidroperoxieicosatetraenoico y procedimientos de utilizacion en el tratamiento de trastornos de la sequedad ocular.
ATE355374T1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
PT868186E (pt) Utilizacao de certos compostos de isoquinolinossulfonilo para tratamento de glaucoma e isquemia ocular
DE69930739D1 (de) Transdermale verwendung von sekretin zur behandlung von autismus
DE69521620D1 (de) Verwendung von 9-deoxyprostaglandinderivaten zur behandlung von glaukom
ATE319474T1 (de) Behandlung von autoimmunkrankheiten durch orale verabreichung von autoantigenen
ATE420857T1 (de) Prostaglandin-derivate zur behandlung von glaukom und ocularer hypertension
EA200000723A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
ATE365550T1 (de) Verwendung von einem protein kinase hemmer wie z.b. genistein bei der behandlung von diabetischer retinopathie
NO990433L (no) Nye forbindelser og blandinger for behandling av sykdommer i forbindelse med tryptase-aktivitet
EA200300560A1 (ru) Улучшенный способ лечения
IE791235L (en) Acyl-derivatives of carnitine.
DE69613693D1 (de) 2-heteroarylalkenylderivate der cyclopentano-heptan(heptaen)säure als therapeutisches mittel zur behandlung des erhöhten augeninnendruckes
TR200400526T4 (tr) Göz kurumasının tedavisi için lipoksin A4 ve analogları
ATE359774T1 (de) Taurinderivate verwendbar in der behandlung von netzhauterkrankungen
DE69930271D1 (de) Medizinische zusammensetzungen zur behandlung von augenerkrankungen
DE60130872D1 (de) Verfahren und mittel zur behandlung und vorbeugung von erkrankungen der hinteren augenkammer
ATE128141T1 (de) Als therapeutische mittel verwendbare substituierte adeninderivate.
NO20044530L (no) Fremgangsmate for behandling av kognitive forstyrrelser
DE69534620D1 (de) Verfahren zur behandlung von augenerkrankungen
ATE161725T1 (de) Verwendung von phosphatdiestern zur behandlung von erkrankungen der retina
RU94016912A (ru) Способ лечения миопии высокой степени и миопического астигматизма средней и высокой степени
Smolin et al. Tretinoin and corneal epithelial wound healing
ATE310517T1 (de) Cabergolin und pramipexol zur behandlung von krankheiten des zentralnervensystems, insbesondere parkinsonscher krankheit
PT986393E (pt) Utilizacao de um nitroxido ou de um seu pro-farmaco no tratamento profilactico e terapeutico do cancro

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties